Subscribe To
Sunpower: supply chain issues are temporary, growth is strong
SunPower has enjoyed strong demand in a fast-growing industry but has faced temporary headwinds due to ...
December 27, 2021, 8:59 pm
Sunpower: supply chain issues are temporary, growth is strong
SunPower has enjoyed strong demand in a fast-growing industry but has faced temporary headwinds due to ...
December 27, 2021, 8:59 pm
Sunpower: supply chain issues are temporary, growth is strong
SunPower has enjoyed strong demand in a fast-growing industry but has faced temporary headwinds due to ...
December 27, 2021, 8:59 pm
Why is everyone talking about peloton this week?
The connected fitness company is reeling from external headwinds -- and now, some negative publicity....
December 18, 2021, 9:15 am
Why is everyone talking about peloton this week?
The connected fitness company is reeling from external headwinds -- and now, some negative publicity....
December 18, 2021, 9:15 am
Why is everyone talking about peloton this week?
The connected fitness company is reeling from external headwinds -- and now, some negative publicity....
December 18, 2021, 9:15 am
Omega healthcare at 9.7% yield is silly cheap, time to buy
Omega Healthcare has seen material share price weakness in recent months. While tenant issues present headwinds, recent developments point to silver l...
December 16, 2021, 10:57 pm
Omega healthcare at 9.7% yield is silly cheap, time to buy
Omega Healthcare has seen material share price weakness in recent months. While tenant issues present headwinds, recent developments point to silver l...
December 16, 2021, 10:57 pm
Omega healthcare at 9.7% yield is silly cheap, time to buy
Omega Healthcare has seen material share price weakness in recent months. While tenant issues present headwinds, recent developments point to silver l...
December 16, 2021, 10:57 pm
Wisdomtree 2022 outlook
The end of the year is often when advisors check in on their overall asset allocation plan, looking at market conditions to determine what ...
December 13, 2021, 7:50 pm
Wisdomtree 2022 outlook
The end of the year is often when advisors check in on their overall asset allocation plan, looking at market conditions to determine what ...
December 13, 2021, 7:50 pm
Wisdomtree 2022 outlook
The end of the year is often when advisors check in on their overall asset allocation plan, looking at market conditions to determine what ...
December 13, 2021, 7:50 pm
Fresenius: the selloff is creating a buying opportunity
Although Fresenius could raise its guidance and reported solid third quarter results, the stock declined pretty steeply in the last few weeks. Freseni...
December 6, 2021, 9:29 pm
Fresenius: the selloff is creating a buying opportunity
Although Fresenius could raise its guidance and reported solid third quarter results, the stock declined pretty steeply in the last few weeks. Freseni...
December 6, 2021, 9:29 pm
Fresenius: the selloff is creating a buying opportunity
Although Fresenius could raise its guidance and reported solid third quarter results, the stock declined pretty steeply in the last few weeks. Freseni...
December 6, 2021, 9:29 pm
Alibaba overhauls e-commerce businesses, appoints new cfo as it faces headwinds on multiple fronts
The Chinese e-commerce giant is up against increased competition, a slowing economy and a regulatory crackdown....
December 5, 2021, 10:14 pm
Alibaba overhauls e-commerce businesses, appoints new cfo as it faces headwinds on multiple fronts
The Chinese e-commerce giant is up against increased competition, a slowing economy and a regulatory crackdown....
December 5, 2021, 10:14 pm
Alibaba overhauls e-commerce businesses, appoints new cfo as it faces headwinds on multiple fronts
The Chinese e-commerce giant is up against increased competition, a slowing economy and a regulatory crackdown....
December 5, 2021, 10:14 pm
Spdr s&p biotech etf: of headwinds and tailwinds
I had rated the SPDR S&P Biotech ETF as bullish in July 2020. The ETF's price spiked by 51% thereafter, and later, regressed to its mean. Historical d...
December 5, 2021, 8:03 am
Spdr s&p biotech etf: of headwinds and tailwinds
I had rated the SPDR S&P Biotech ETF as bullish in July 2020. The ETF's price spiked by 51% thereafter, and later, regressed to its mean. Historical d...
December 5, 2021, 8:03 am